End-of-Reporting Period Dialysis Service Utilization Assessment
This test evaluates the proportion of dialysis patients receiving services at the end of the reporting period, often used to monitor healthcare delivery metrics in dialysis programs.
This is a programmatic assessment, not a direct patient blood or urine test.
Key facts at a glance
- LOINC
- 64360-1
- Short code
- TOTALDIALYSISPATIENTSRECEIVINGSERVICESATENDOFREPORTINGPERIOD
- Synonyms
- —
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
This test does not measure specific biochemical markers in your blood or body fluids. Instead, it assesses the percentage of patients in a dialysis program who received services at the end of a defined timeframe. It helps healthcare providers and administrators track service coverage and identify areas for improvement in care delivery.
Why It Matters in Dialysis Care
Understanding how many dialysis patients received services at the end of a period helps ensure consistent access to care. It may be used to evaluate program efficiency, identify gaps in service delivery, and improve patient outcomes by addressing barriers to care.
How It’s Conducted
This test is not performed on a blood sample or other bodily fluid. Instead, it relies on administrative data collected from dialysis centers to calculate the proportion of patients receiving services during the reporting period.
What You Can Expect
You will not receive a lab result or specific instructions related to this test. It is typically reviewed by healthcare administrators or program managers and does not require any action from you.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This assessment is primarily used to evaluate the effectiveness of dialysis service delivery systems. It may highlight disparities in care access, inform policy changes, or guide resource allocation to ensure equitable and comprehensive care for all patients.
Frequently asked questions
Why would my healthcare provider request this test?
Does this test involve a blood draw or other bodily fluid sample?
How often is this test performed?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy